ドラッグデリバリー市場-世界の産業規模、シェア、動向、機会、予測、投与経路別、用途別、地域別、競合別、2019～2029年

ドラッグデリバリーの世界市場は、2023年に15億2,000万米ドルと評価され、2029年のCAGRは5.25%で、予測期間中に着実な成長が予測されています。

より効果的で患者に優しい治療法に対する世界の需要が高まるにつれ、ドラッグデリバリー市場は技術革新の焦点となっています。ドラッグデリバリー市場には、治療の投与を改善するために設計された幅広い技術やデバイスが含まれます。これらの技術革新は、薬剤のバイオアベイラビリティを高め、副作用を軽減し、最終的に患者の転帰を改善することを目的としています。市場には、経口剤、注射剤、経皮剤、吸入剤、埋め込み型デバイスなど、さまざまな送達システムが含まれます。

生物製剤や標的療法の使用が増加していることが、高度なドラッグデリバリーシステムに対する需要を押し上げています。これらの洗練された分子は、正確なターゲティングと有効性を確保するために特定のデリバリーメカニズムを必要とすることが多いです。使いやすさとコンプライアンスの改善に焦点を当てた、患者中心のドラッグデリバリーソリューションが重視されるようになってきています。ドラッグデリバリーにおけるナノ技術の統合は、ナノ粒子やナノキャリアの開発を可能にし、注目を集めています。スマート・ドラッグデリバリー・デバイスやデジタルプラットフォームを含むコネクテッド・ヘルスソリューションの台頭により、リアルタイムのモニタリングやデータ収集が可能になりました。この接続性により、医療専門家が患者のアドヒアランスを追跡し、それに応じて治療計画を調整する能力が強化されます。

市場の促進要因

慢性疾患の増加と高齢化がドラッグデリバリーの世界市場を牽引

医療支出の増加がドラッグデリバリーの世界市場を牽引

主要市場課題

規制上のハードル

技術の進歩

コスト制約

製剤の複雑さ

患者のアドヒアランス

競合と市場の飽和状態

世界経済要因

サプライチェーンの問題

主要市場動向

技術の進歩

セグメント別洞察

投与経路洞察

用途別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 ドラッグデリバリーの世界市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 投与経路別（経口ドラッグデリバリー、経鼻ドラッグデリバリー、点眼ドラッグデリバリー、局所ドラッグデリバリー、その他）
  • 用途別（がん、感染症、糖尿病、心血管疾患、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • 投与経路別
  • 用途別
  • 地域別

第5章 アジア太平洋のドラッグデリバリー市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 投与経路別
  • 用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のドラッグデリバリー市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 投与経路別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のドラッグデリバリー市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 投与経路別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のドラッグデリバリー市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 投与経路別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのドラッグデリバリー市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 投与経路別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と新興国市場開拓

• 製品発表
• 合併・買収

第12章 ドラッグデリバリーの世界市場のSWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Johnson Johnson
• Novartis International AG
• F. Hoffmann-La Roche AG
• Pfizer Inc.
• Bayer AG
• Antares Pharma, Inc.
• Becton, Dickinson and Company
• GlaxoSmithKline plc
• Merck Co., Inc.
• Amgen, Inc.
• AbbVie Inc.

第15章 戦略的提言

第16章 戦略的提言当社について免責事項

Global Pharmaceutical Drug Delivery Marketwas valued at USD 1.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029.The pharmaceutical industry is witnessing a paradigm shift with continuous advancements in drug delivery technologies. As the global demand for more effective and patient-friendly treatment options rises, the pharmaceutical drug delivery market has become a focal point for innovation.The pharmaceutical drug delivery market encompasses a wide range of technologies and devices designed to improve the administration of therapeutic agents. These innovations aim to enhance drug bioavailability, reduce side effects, and ultimately improve patient outcomes. The market includes various delivery systems such as oral, injectable, transdermal, inhalable, and implantable devices.

The increasing use of biologics and targeted therapies has driven the demand for advanced drug delivery systems. These sophisticated molecules often require specific delivery mechanisms to ensure precise targeting and efficacy.There is a growing emphasis on patient-centric drug delivery solutions, focusing on ease of use and improved compliance. Innovations like wearable devices and self-administration tools empower patients to manage their treatment regimens more effectively.The integration of nanotechnology in drug delivery has gained prominence, allowing for the development of nanoparticles and nano-carriers. These nanoscale systems enhance drug stability, solubility, and targeted delivery to specific cells or tissues.The rise of connected health solutions, including smart drug delivery devices and digital platforms, enables real-time monitoring and data collection. This connectivity enhances healthcare professionals' ability to track patient adherence and adjust treatment plans accordingly.

Key Market Drivers

Rising Chronic Diseases and Aging Population is Driving the Global Pharmaceutical Drug Delivery Market

In an era where chronic diseases are on the rise, and the world's population is aging, the pharmaceutical industry is evolving to meet the growing healthcare challenges. One of the key drivers transforming the landscape is the Global Pharmaceutical Drug Delivery Market. The increasing prevalence of chronic diseases, coupled with an aging population, has spurred the demand for innovative drug delivery solutions.The global healthcare landscape is undergoing a significant transformation with the increasing burden of chronic diseases. Conditions such as diabetes, cardiovascular diseases, and cancer are becoming more prevalent, requiring effective and targeted drug delivery methods. Conventional drug administration routes face limitations in terms of efficacy and patient compliance. As a result, there is a growing need for advanced drug delivery systems that offer enhanced precision, reduced side effects, and improved patient outcomes.

The world's population is aging at an unprecedented rate, leading to a surge in age-related health issues. As individuals age, the prevalence of chronic diseases tends to increase, creating a higher demand for pharmaceutical interventions. The elderly population often faces challenges related to medication adherence and tolerance. Innovative drug delivery systems address these concerns by providing solutions that are tailored to the specific needs of older patients, promoting better therapeutic outcomes and quality of life.The pharmaceutical drug delivery market is witnessing a wave of innovations, driven by advancements in technology and research. Novel drug delivery systems, such as nanotechnology-based carriers, implantable devices, and targeted drug delivery, are gaining prominence. These innovations aim to improve the efficiency of drug delivery, enhance drug bioavailability, and minimize adverse effects.The rising awareness of the importance of personalized medicine has also contributed to the growth of the drug delivery market. Tailoring drug delivery methods to individual patient needs allows for more effective and precise treatment strategies. Patient-centric approaches not only improve therapeutic outcomes but also enhance patient satisfaction and compliance.

Rising Healthcare Expenditure is Driving the Global Pharmaceutical Drug Delivery Market

In recent years, the global healthcare landscape has witnessed a significant rise in expenditure, driven by the growing demand for advanced treatment options and innovative pharmaceutical solutions. As a result, the pharmaceutical drug delivery market has emerged as a focal point of innovation and investment.The pharmaceutical industry has experienced remarkable advancements in drug delivery technologies, offering more sophisticated and patient-friendly options. Innovations such as nanotechnology, microparticles, and implantable devices have revolutionized drug administration, enabling precise dosage control and targeted delivery to specific organs or tissues. These advancements not only improve patient outcomes but also contribute to the overall efficiency of healthcare systems.

The era of personalized medicine is gaining momentum, with a focus on tailoring treatments to individual patient characteristics. This shift towards precision therapeutics has fueled the demand for drug delivery systems that can accommodate diverse patient needs. The pharmaceutical drug delivery market is responding by developing customizable and patient-specific delivery mechanisms, allowing for optimized treatment regimens.Governments and regulatory bodies worldwide are recognizing the importance of advancing drug delivery technologies to address healthcare challenges effectively. Supportive regulatory frameworks and increased funding for research and development in the pharmaceutical sector have created a conducive environment for innovation. This has led to a proliferation of startups and collaborations within the pharmaceutical drug delivery market.Patients are increasingly seeking non-invasive and convenient drug delivery methods that improve treatment adherence and overall healthcare experiences. This has prompted pharmaceutical companies to invest in technologies such as oral drug delivery, transdermal patches, and inhalation systems. These methods not only enhance patient compliance but also contribute to the market growth of pharmaceutical drug delivery systems.

Key Market Challenges

Regulatory Hurdles

Regulatory frameworks vary across regions, making it challenging for pharmaceutical companies to navigate and comply with different standards. Strict regulations can impact the speed at which new drug delivery technologies are introduced to the market, leadin to delays and increased costs.

Technological Advancements

While technological advancements present opportunities for innovation, they also pose challenges in terms of implementation and adaptation. Developing and integrating cutting-edge drug delivery technologies requires substantial investment and expertise, often causing delays in product development.

Cost Constraints

The pharmaceutical industry operates in a highly cost-sensitive environment. Developing and commercializing novel drug delivery systems can be expensive, and cost considerations can limit the accessibility of advanced technologies, especially in developing regions.

Complexity in Drug Formulation

The compatibility of drug formulations with delivery systems is a critical factor. Some drugs may not be suitable for certain delivery methods, leading to challenges in finding appropriate technologies that can effectively deliver the medication without compromising its efficacy.

Patient Adherence

Ensuring patient adherence to prescribed medications is a common challenge. Complex drug delivery systems or frequent dosing regimens may lead to non-compliance among patients, affecting the overall effectiveness of the treatment.

Competition and Market Saturation

The pharmaceutical drug delivery market is highly competitive, with numerous companies vying for market share. As a result, the saturation of certain delivery technologies in the market can limit opportunities for new entrants and pose challenges for existing players to differentiate their products.

Global Economic Factors

Economic fluctuations and uncertainties can impact funding for research and development projects. Pharmaceutical companies heavily rely on consistent investment to drive innovation, and economic downturns may hinder the progress of drug delivery technologies.

Supply Chain Issues

Global supply chain disruptions, as witnessed during events like the COVID-19 pandemic, can affect the production and distribution of drug delivery devices. Dependence on specific regions for manufacturing components may lead to delays and shortages.

Key Market Trends

Technological Advancements

In the ever-evolving landscape of healthcare, technological advancements play a pivotal role in shaping the future of pharmaceuticals. The Global Pharmaceutical Drug Delivery Market is experiencing a revolutionary surge, driven by a relentless wave of innovation. As new breakthroughs emerge, the delivery of pharmaceutical drugs is becoming more efficient, precise, and patient-centric than ever before.Traditionally, pharmaceutical drug delivery has been a straightforward process. Medications were often administered through oral tablets or injections. However, the landscape is rapidly shifting with advancements in technology, paving the way for novel approaches to drug delivery. Nanotechnology, for instance, has opened up new frontiers by allowing the development of nanoparticles that can deliver drugs directly to targeted cells. This precision minimizes side effects and enhances the therapeutic impact of medications. The advent of smart drug delivery systems, such as implants and patches, is also contributing to the market's growth, providing controlled release mechanisms and improving patient compliance.

One of the most significant trends driving the pharmaceutical drug delivery market is the shift towards personalized medicine. Thanks to advancements in genomics and diagnostics, healthcare providers can now tailor drug delivery systems to individual patient needs. This not only maximizes the efficacy of treatments but also minimizes adverse reactions, making healthcare more patient-centric. Inhalable drug delivery systems, for example, are gaining popularity for respiratory conditions. They offer a non-invasive and efficient way to deliver medications directly to the lungs, providing faster relief with reduced systemic side effects. The rise of 3D printing technology is also enabling the customization of drug delivery devices, allowing for the creation of patient-specific solutions.

The integration of technology into healthcare, often referred to as connected health, is playing a pivotal role in the pharmaceutical drug delivery market. Smart devices, such as wearable sensors and connected inhalers, are providing real-time data on patient health and adherence to prescribed medications. This data not only empowers healthcare providers with valuable insights but also allows for timely interventions, improving overall patient outcomes.The impact of technological advancements in drug delivery is not limited to a specific region. The global pharmaceutical drug delivery market is witnessing widespread adoption of these innovative solutions. As developing countries embrace modern healthcare practices, the demand for efficient drug delivery systems is on the rise, further fuelling market growth.

Segmental Insights

Route of Administration Insights

Basedon the category of Route of Administration, topical drug delivery emerged as the dominant player in the global market for Pharmaceutical Drug Delivery in 2023.Traditional oral medications, though effective, often face challenges such as variable absorption rates, degradation in the gastrointestinal tract, and systemic side effects. In response to these limitations, pharmaceutical researchers have increasingly turned to alternative delivery methods, with topical drug delivery at the forefront. One of the primary advantages of topical drug delivery is its ability to deliver medication directly to the site of action, minimizing systemic exposure. This targeted approach not only enhances the therapeutic effect but also reduces the risk of adverse reactions associated with systemic drug distribution.The dominance of topical drug delivery is particularly evident in the treatment of dermatological disorders. Conditions such as psoriasis, eczema, and acne have witnessed a paradigm shift in treatment strategies, with topical formulations becoming the preferred choice for both patients and healthcare providers. The ease of application and reduced systemic side effects contribute to the growing popularity of topical solutions in dermatology.While dermatology remains a focal point, the influence of topical drug delivery extends beyond skin-related conditions. Researchers are exploring its potential in delivering medications for pain management, arthritis, and even systemic diseases. Transdermal patches, for instance, offer a non-invasive and convenient way to administer drugs, ensuring a steady release over an extended period.

Application Insights

TheInfectious Diseasessegment is projected to experience rapid growth during the forecast period. Infectious diseases, ranging from viral infections to bacterial outbreaks, pose a constant threat to global health. Recent events, such as the COVID-19 pandemic, have underscored the need for effective and targeted drug delivery systems to combat infectious agents. Pharmaceutical drug delivery plays a pivotal role in enhancing the efficacy of treatments while minimizing side effects, making it a key player in the battle against infectious diseases.The pharmaceutical industry is experiencing a paradigm shift with the development of advanced drug delivery technologies. Nanotechnology, microfabrication, and targeted delivery systems are revolutionizing the way drugs are administered, ensuring precise and efficient treatment. These innovations are particularly valuable in infectious diseases, where targeted delivery to specific cells or tissues is essential for optimal therapeutic outcomes.

Regional Insights

In 2023, North America solidified its position as the leading force in the global Pharmaceutical Drug Delivery market, commanding the largest market share in terms of value. The region benefits from a robust research and development infrastructure, supported by ongoing investments from pharmaceutical companies and academic institutions in cutting-edge technologies. This steadfast dedication to innovation has yielded advanced drug delivery systems that significantly enhance therapeutic outcomes. Collaboration among pharmaceutical companies, research institutions, and technology firms in North America has cultivated an environment conducive to groundbreaking advancements in drug delivery. These strategic partnerships facilitate the exchange of expertise and resources, expediting the development and commercialization of innovative drug delivery solutions.

Key Market Players

Johnson Johnson

Novartis International AG

F. Hoffmann-La Roche AG

Pfizer Inc.

Bayer AG

Antares Pharma, Inc.

Becton, Dickinson and Company

GlaxoSmithKline plc

Merck Co., Inc.

Amgen, Inc.

AbbVie Inc.

Report Scope:

In this report, the GlobalPharmaceutical Drug DeliveryMarket has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Drug Delivery Market,By Route of Administration:

• Oral drug delivery
• Nasal drug delivery Ocular drug delivery
• Topical drug delivery
• Others

Pharmaceutical Drug Delivery Market,By Application:

• Cancer
• Infectious Diseases
• Diabetes
• Cardiovascular Diseases
• Others

Pharmaceutical Drug Delivery Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Pharmaceutical Drug Delivery Market.

Available Customizations:

Global Pharmaceutical Drug Delivery market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Pharmaceutical Drug Delivery Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value
• 4.2.Market Share Forecast
  • 4.2.1.By Route of Administration (Oral drug delivery, Nasal drug delivery, Ocular drug delivery, Topical drug delivery, Others)
  • 4.2.2.By Application (Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Others)
  • 4.2.3.By Region
  • 4.2.4.By Company (2023)
• 4.3.Market Map
  • 4.3.1.By Route of Administration
  • 4.3.2.By Application
  • 4.3.3.By Region

5.Asia Pacific Pharmaceutical Drug Delivery Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Route of Administration
  • 5.2.2.By Application
  • 5.2.3.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Pharmaceutical Drug Delivery Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Route of Administration
      • 5.3.1.2.2.By Application
  • 5.3.2.India Pharmaceutical Drug Delivery Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Route of Administration
      • 5.3.2.2.2.By Application
  • 5.3.3.Australia Pharmaceutical Drug Delivery Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Route of Administration
      • 5.3.3.2.2.By Application
  • 5.3.4.Japan Pharmaceutical Drug Delivery Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Route of Administration
      • 5.3.4.2.2.By Application
  • 5.3.5.South Korea Pharmaceutical Drug Delivery Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Route of Administration
      • 5.3.5.2.2.By Application

6.Europe Pharmaceutical Drug Delivery Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Route of Administration
  • 6.2.2.By Application
  • 6.2.3.By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Pharmaceutical Drug Delivery Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Route of Administration
      • 6.3.1.2.2.By Application
  • 6.3.2.Germany Pharmaceutical Drug Delivery Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Route of Administration
      • 6.3.2.2.2.By Application
  • 6.3.3.Spain Pharmaceutical Drug Delivery Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Route of Administration
      • 6.3.3.2.2.By Application
  • 6.3.4.Italy Pharmaceutical Drug Delivery Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Route of Administration
      • 6.3.4.2.2.By Application
  • 6.3.5.United Kingdom Pharmaceutical Drug Delivery Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Route of Administration
      • 6.3.5.2.2.By Application

7.North America Pharmaceutical Drug Delivery Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Route of Administration
  • 7.2.2.By Application
  • 7.2.3.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Pharmaceutical Drug Delivery Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Route of Administration
      • 7.3.1.2.2.By Application
  • 7.3.2.Mexico Pharmaceutical Drug Delivery Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Route of Administration
      • 7.3.2.2.2.By Application
  • 7.3.3.Canada Pharmaceutical Drug Delivery Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Route of Administration
      • 7.3.3.2.2.By Application

8.South America Pharmaceutical Drug Delivery Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Route of Administration
  • 8.2.2.By Application
  • 8.2.3.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Pharmaceutical Drug Delivery Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Route of Administration
      • 8.3.1.2.2.By Application
  • 8.3.2.Argentina Pharmaceutical Drug Delivery Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Route of Administration
      • 8.3.2.2.2.By Application
  • 8.3.3.Colombia Pharmaceutical Drug Delivery Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Route of Administration
      • 8.3.3.2.2.By Application

9.Middle East and Africa Pharmaceutical Drug Delivery Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Route of Administration
  • 9.2.2.By Application
  • 9.2.3.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Pharmaceutical Drug Delivery Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Route of Administration
      • 9.3.1.2.2.By Application
  • 9.3.2.Saudi Arabia Pharmaceutical Drug Delivery Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Route of Administration
      • 9.3.2.2.2.By Application
  • 9.3.3.UAE Pharmaceutical Drug Delivery Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Route of Administration
      • 9.3.3.2.2.By Application

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Pharmaceutical Drug Delivery Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1.Johnson Johnson
  • 14.1.1.Company Snapshot
  • 14.1.2.Product Services
  • 14.1.4.Financials (In case of listed)
  • 14.1.5.Recent Developments
  • 14.1.6.SWOT Analysis
• 14.2.Novartis International AG
• 14.3.F. Hoffmann-La Roche AG
• 14.4.Pfizer Inc.
• 14.5.Bayer AG
• 14.6.Antares Pharma, Inc.
• 14.7.Becton, Dickinson and Company
• 14.8.GlaxoSmithKline plc
• 14.9.Merck Co., Inc.
• 14.10.Amgen, Inc.
• 14.11.AbbVie Inc.

15.Strategic Recommendations

16. About Us Disclaimer